2 results
Approved WMOCompleted
To demonstrate the additive IOP lowering effect of SIMBRINZA (dosed BID) when added to DUOTRAV solution in subjects with open-angle glaucoma or ocular hypertension.
Approved WMOPending
to assess the diagnostic accuracy of CSI (at 5, 10 and 15 cm proximal to the upper border of the lower esophageal sphincter) for the presence of active disease and/or complete remission in pediatric EoE.